Biopharmaceutical research companies have been and continue to be a source of jobs, tax revenue, and research spending in Pennsylvania.
A study by Battelle Technology Partnership Practice found that in 2011, the industry supported more than 211,000 jobs throughout Pennsylvania. Wages and benefits for employees whose jobs were supported by the biopharmaceutical sector resulted in about $873 million in federal taxation and $133 million in state taxes.
Biopharmaceutical research companies supported the generation of $51.7 billion in economic activity in the state, including the direct economic output of the sector itself, the output of the sector’s vendors and suppliers, and the output generated by the buying power of its workforce.
“The 6,400 plus clinical trials conducted throughout our great Commonwealth in the past decade are crucial investments for both our patients and the future. They provide the means for biopharmaceutical companies in Pennsylvania to engage with our local research institutions and contract research organizations, and have provided our talented local scientists the opportunity to lead the charge in the development of new therapies." --State Representative Scott Petri